Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon

Cancer Epidemiology

Volumn 38, Issue 2, 2014, Pages 137-143

  Stolka, Kristen ^a   Ndom, Paul ^b   Hemingway Foday, Jennifer ^a   Iriondo Perez, Jeniffer ^a   Miley, Wendell ^c   Labo, Nazzarena ^c,d   Stella, Jennifer ^e   Abassora, Mahamat ^f   Woelk, Godfrey ^f,g   Ryder, Robin ^h   Whitby, Denise ^c   Smith, Jennifer S ⁱ  

^a RTI INTERNATIONAL   (United States)

^b Après Gendarmerie Nationale   (Cameroon)

^c FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Expanded Program on Immunization   (Cameroon)

^g ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ IL   (United States)

Author keywords

Cameroon; Human herpesvirus 8 (HHV 8); Human Immunodeficiency Virus (HIV); Kaposi's sarcoma (KS); Kaposi's sarcoma herpesvirus (KSHV); Risk factors

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; K8 1 ANTIGEN; ORF 73 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BED NET; BLOOD; CAMEROON; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; FAMILY HISTORY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEOPLASM; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; SALIVA; TRADITIONAL HEALER; YOUNG ADULT; EPIDEMIOLOGY; HIV INFECTIONS; HUMAN HERPESVIRUS 8; ISOLATION AND PURIFICATION; PATHOLOGY; SARCOMA, KAPOSI; VIROLOGY;

ADULT; CAMEROON; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPESVIRUS 8, HUMAN; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SARCOMA, KAPOSI; YOUNG ADULT;

EID: 84898037109     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2014.02.006     Document Type: Article

References (42)

1. Haverkos H.W. Multifactorial etiology of Kaposi's sarcoma: a hypothesis. J Biosci 2008, 33(December (5)):643-651.
2. Antman K., Chang Y. Kaposi's sarcoma. N Engl J Med 2000, 342(14):1027-1038.
3. Phipps W., Ssewankambo F., Nguyen H., Saracino M., Wald A., Corey L., et al. Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda. PLoS ONE 2010, 5(January (11)):e13936.
4. Centers for Disease Control (CDC) Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men - New York City and California. Morb Mortal Wkly Rep (MMWR) 1981, 306-P308.
5. Silverberg M.J., Neuhaus J., Bower M., Gey D., Hatzakis A., Henry K., et al. Risk of cancers during interrupted antiretroviral therapy in the SMART study. AIDS (London, England) 2007, 21(September (14)):1957-1963.
6. Whitby D., Howard M.R., Tenant-Flowers M., Brink N.S., Copas A., Boshoff C., et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995, 346(September (8978)):799-802.
7. Engels E.A., Pfeiffer R.M., Goedert J.J., Virgo P., McNeel T.S., Scoppa S.M., et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS (London, England) 2006, 20(August (12)):1645-1654.
8. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266(5192):1865-1869.
9. Simpson G.R., Schulz T.F., Whitby D., Cook P.M., Boshoff C., Rainbow L., et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996, 348(October (9035)):1133-1138.
10. Iscovich J., Boffetta P., Franceschi S., Azizi E., Sarid R. Classic Kaposi Sarcoma: epidemiology and risk factors. Cancer 2000, 8-12.
11. Bourboulia D., Whitby D., Boshoff C., Newton R., Beral V., Carrara H., et al. Serologic evidence for mother-to-child transmission of Kaposi Sarcoma-associated herpesvirus infection. J Am Med Assoc 1998, 280(July (1)):28.
12. Marcelin A., Gorin I., Morand P., Ait-arkoub Z., Deleuze J., Morini J., et al. Quantification of Kaposi's sarcoma-associated herpesvirus in blood, oral mucosa, and saliva in patients with Kaposi's sarcoma. AIDS Res Hum Retroviruses 2004, 20(7):704-708.
13. Mbulaiteye S.M., Goedert J.J. Human herpesvirus 8 seropositivity in rural Uganda: maturation of sero-epidemiological studies. J Infect Dis 2011, 203:575-577.
14. Malope-kgokong B.I., Macphail P., Mbisa G., Ratshikhopha E., Maskew M., Stein L., et al. Kaposi's sarcoma associated-herpes virus (KSHV) seroprevalence in pregnant women in South Africa. Infect Agents Cancer 2010, 5(14):1-8.
15. Martin J.N., Ganem D.E., Osmond D.H., Page-Shafer K.A., Macrae D., Kedes D.H. Sexual transmission the natural history of human herpesvirus 8 infection. N Engl J Med 1998, 338:948-954.
16. Gessain A., Mauclère P., van Beveren M., Plancoulaine S., Ayouba A., Essame-Oyono J.L., et al. Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa. Int J Cancer 1999, 81(April (2)):189-192.
17. Dollard S.C., Butler L.M., Jones A.M.G., Mermin J.H., Chipato T., Shiboski C.H., et al. Substantial regional difference in human herpesvirus 8 seroprevalence in Sub-Saharan Africa: insights on the origin of the KS Belt. Int J Cancer 2010, 127(10):2395-2401.
18. Ziegler J.L. Endemic Kaposi's sarcoma in Africa and local volcanic soils. Lancet 1993, 342(January (22)):1348-1351.
19. Pfeiffer R.M., Wheeler W.A., Mbisa G., Whitby D., Goedert J.J., de Thé G., et al. Geographic heterogeneity of prevalence of the human herpesvirus 8 in Sub-Saharan Africa: clues about etiology. Ann Epidemiol 2010, 20(December (12)):958-963.
20. Dedicoat M., Newton R. Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Br J Cancer 2003, 88(January (1)):1-3.
21. Joint United Nations Programme on HIV/AIDS (UNAIDS) Global report: UNAIDS report on global AIDS epidemic 2010 2010.
22. Mbuagbaw J., Pisoh C., Mbuagbaw L., Bengondo C., Kegoum B., Bengono G., et al. Prevalence and characteristics of Human Immunodeficiency Virus associated Kaposi Sarcoma. Internet J Oncol 2008, 5(2).
23. Rezza G., Tchangmena B., Andreoni M., Bugarini R., Toma L., Bakary D.K., et al. Prevalence and risk factors for human herpesvirus infection in Northern Cameroon. Sex Transm Dis 2000, 27(3):159-164.
24. Price A.J., Ndom P., Atenguena E., Mambou Nouemssi J.P., Ryder R.W. Cancer care challenges in developing countries. Cancer 2012, 118(July (14)):3627-3635.
25. Divaris K., Newman J., Hemingway-Foday J., Akam W., Balimba A., Dusengamungu C., et al. Adult HIV care resources, management practices and patient characteristics in the phase 1 IeDEA Central Africa cohort. J Int AIDS Soc 2012, 15(January (2)):17422.
26. Mbisa G.L., Miley W., Gamache C.J., Gillette W.K., Esposito D., Hopkins R., et al. Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA. J Immunol Methods 2010, 356(April (1-2)):39-46.
27. Whitby D., Marshall V.A., Bagni R.K., Miley W.J., McCloud T.G., Hines-Boykin R., et al. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions. Int J Cancer 2007, 120(2):321-328.
28. Wakeham K., Webb E.L., Sebina I., Muhangi L., Miley W., Johnson W.T., et al. Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women. Infect Agents Cancer 2011, 6(January (15)):1-7.
29. Ziegler J., Newton R., Bourboulia D., Casabonne D., Beral V., Mbidde E., et al. Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda. Int J Cancer 2003, 103(January (2)):233-240.
30. Ziegler J.L., Newton R., Katongole-mbidde E., Mbulataiye S., De Cock K., Wabinga H., et al. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda. AIDS 1997, 11(13):1619-1626.
31. Nkuo-Akenji T., Ntonifor N.N., Ndukum M.B., Kimbi H.K., Abongwa E.L., Nkwescheu A., et al. Environmental factors affecting malaria parasite prevalence in rural Bolifamba, South-West Cameroon. Afr J Health Sci 2006, 13(1):40-46.
32. Nuwaha F. Factors influencing the use of bed nets in Mbarara municipality of Uganda. Am J Trop Med Hyg 2001, 65(December (6)):877-882.
33. Cook-Mozaffari P., Newton R., Berai V., Burkitt D.P. The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer 1998, 78(11):1521-1528.
34. Mbulaiteye S.M., Biggar R.J., Pfeiffer R.M., Bakaki P.M., Gamache C., Owor A.M., et al. Water, socioeconomic factors, and human herpesvirus 8. Epidemiol Soc Sci 2005, 38(4):474-479.
35. Gemperli A., Sogoba N., Fondjo E., Mabaso M., Bagayoko M., Briët O.J.T., et al. Mapping malaria transmission in West and Central Africa. Trop Med Int Health 2006, 11(July (7)):1032-1046.
36. Pelser C., Dazzi C., Graubard B.I., Lauria C., Vitale F., Goedert J.J. Risk of classic Kaposi Sarcoma with residential exposure to volcanic and related soils in Sicily. Ann Epidemiol 2009, 19(August (8)):597-601.
37. Davis D.A., Rinderknecht A.S., Zoeteweij J.P., Aoki Y., Read-Connole E.L., Tosato G., et al. Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. Blood 2001, 97(May (10)):3244-3250.
38. Reece J.J., Siracusa M.C., Southard T.L., Brayton C.F., Urban J.F., Scott A.L. Hookworm-induced persistent changes to the immunological environment of the lung. Infect Immun 2008, 76(August (8)):3511-3524.
39. Asito A.S., Moormann A.M., Kiprotich C., Ng'ang'a Z.W., Ploutz-Snyder R., Rochford R. Alterations on peripheral B cell subsets following an acute uncomplicated clinical malaria infection in children. Malar J 2008, 7:238.
40. Ziegler J.L., Simonart T., Snoeck R. Kaposi's sarcoma, oncogenic viruses, and iron. J Clin Virol 2001, 20:127-130.
41. Gray R.H., Wawer M.J. Probability of heterosexual HIV-1 transmission per coital act in Sub-Saharan Africa. J Inf Dis 2012, 205(February (3)):351-352.
42. De Sanjose S., Mbisa G., Perez-Alvarez S., Benavente Y., Sukvirach S., Hieu N.T., et al. Geographic variation in the prevalence of Kaposi Sarcoma-associated herpesvirus and risk factors for transmission. J Infect Dis 2009, 199(May (10)):1449-1456.